AGP Executive Report

Last update: 10 hours ago

Sports & Health Travel: With the 2026 World Cup kicking off in 48 hours, a UK travel-insurance warning is getting attention: almost half of Brits risk costly medical bills abroad by not having a GHIC (Global Health Insurance Card), which can help cover state-provided care in Europe at local cost—though it doesn’t replace travel insurance. Pharma & Bone Health: CinnaGen says it has become the first Iranian pharma company to win EU approval for its osteoporosis medicine teriparatide (Zandoriah), following EMA review under EU biosimilar rules. Liechtenstein in the Mix (Sports Governance): Liechtenstein’s Alexander Ospelt is in the running for FIS president, as Johan Eliasch argues centralising ski commercial rights has boosted revenues and could raise athlete earnings. Local Wellness & Community: In Virginia, U.S. Rep. Donald Beyer returned to his district for a community potluck after a court restored the prior map—an example of how local civic life keeps moving even amid political shifts. Science & Human Health: Nevis launched the Caribbean’s first space life sciences experiment, studying how gravity changes affect human immune cells, with collaboration involving the University of Zurich and CSA Switzerland and Liechtenstein.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
May 31, 2026

St. Kitts and Nevis launches first space life sciences experiment

EIN Presswire

fallback image
Apr. 3, 2026

Virella files European patent on SIRT6 activators after lifespan gains in worms

EIN Presswire

fallback image
May 5, 2026

CEO Insight's Investors Guide focuses on trust and cross-border capital

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Liechtenstein: Fintech and Wider Digital Development in 2026

Liechtenstein: Fintech and Wider Digital Development in 2026

Piyush Goyal to visit Switzerland to discuss India-EFTA TEPA

Piyush Goyal to visit Switzerland to discuss India-EFTA TEPA

CinnaGen secures EU approval for osteoporosis drug in historic first for Iranian pharma

CinnaGen secures EU approval for osteoporosis drug in historic first for Iranian pharma

Top 10 richest countries in the world in 2026 by GDP: From Liechtenstein to Denmark

Top 10 richest countries in the world in 2026 by GDP: From Liechtenstein to Denmark

BIS Issues Procedures for Onshoring Agreements to Mitigate 100% Tariffs on Patented Pharmaceuticals

BIS Issues Procedures for Onshoring Agreements to Mitigate 100% Tariffs on Patented Pharmaceuticals


fallback image
May 19, 2026

SERB Pharmaceuticals to acquire European and MENA rights to Idefirix® (imlifidase) from Hansa Biopharma for €115 million

GlobeNewswire, Inc.

fallback image
May 18, 2026

New Memoranda pave the way for €50 million in investments in local development and public health

Government of Slovenia

fallback image
May 14, 2026

Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

GlobeNewswire, Inc.

fallback image
Mar. 30, 2026

4BIO Capital strengthens investment leadership with appointment of Therese Liechtenstein as Partner and Tetsu Maruyama as Venture Partner

GlobeNewswire, Inc.

fallback image
Jul. 28, 2025

Zevra Therapeutics Submits Marketing Authorization Application to European Medicines Agency to Review Arimoclomol for the Treatment of Niemann-Pick Disease Type C

GlobeNewswire, Inc.

fallback image
May 22, 2026

European Commission grants marketing authorization to Pharming’s Joenja® (leniolisib) – the first approved treatment for APDS in the European Union

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: What Albania Teaches us About Kushner's Real Estate Tactics
Play
What Albania Teaches us About Kushner's Real Estate Tactics
YouTube video thumbnail: Sagrada Familia Nears Completion, Revealing Secrets of Gaudí's Vision
Play
Sagrada Familia Nears Completion, Revealing Secrets of Gaudí's Vision
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Kyiv Hit Russian Military Plant Using Ukrainian-Made Flamingo Missile, Zelenskyy Says
Play
Kyiv Hit Russian Military Plant Using Ukrainian-Made Flamingo Missile, Zelenskyy Says
YouTube video thumbnail: Riots Erupt in Northern Ireland After Stabbing Suspect Charged
Play
Riots Erupt in Northern Ireland After Stabbing Suspect Charged

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.